MedPath

IVASWIFT 5 (IVABRADINE TABLETS 5MG)

Registration Number: MAL20046114AZ

Approved
Approval ID

ad76494d220d22d4

Registration Number

MAL20046114AZ

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

4 x 14 TabletsAvailable
Package Size: 4 x 14 Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

Ivabradine OxalateActive
Monograph: ivabradine oxalate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

IVASWIFT 5 (IVABRADINE TABLETS 5MG) - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform